Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?

Nature Clinical Practice Rheumatology volume 1, pages 72–73 (2005)Cite this article

boxed-textBuyon JP et al. (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Int Med 142: 953–962

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. NIH State of the Science Panel (2005) National Institutes of Health State of the Science Conference Statement: management of menopause-related symptoms. Ann Int Med 142: 1003–1013

  2. Rossauw JE et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333

    Article  Google Scholar 

  3. Sanchez-Guerrero J et al. (1995) Postmenopausal hormone therapy and the risk of developing systemic lupus erythematosus. Ann Int Med 122: 430–433

    Article  CAS  Google Scholar 

  4. Julkunen HA (1991) Oral contraceptives in systemic lupus erythematosus: side effects and influence on the activity of SLE. Scand J Rheumatol 20: 427–433

    Article  CAS  Google Scholar 

  5. Arden NK et al. (1994) Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE). Lupus 3: 11–13

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine in the Division of Rheumatology and the Program Director for the General Clinical Research Center at Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

    Rosalind Ramsey-Goldman

Authors
  1. Rosalind Ramsey-Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rosalind Ramsey-Goldman.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramsey-Goldman, R. Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?. Nat Rev Rheumatol 1, 72–73 (2005). https://doi.org/10.1038/ncprheum0045

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0045

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing